Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7258.405 (Published 12 August 2000) Cite this as: BMJ 2000;321:405
Data supplement
The participating centres for UKPDS 36 were Radcliffe Infirmary, Oxford; Royal Infirmary, Aberdeen; General Hospital, Birmingham; Hammersmith Hospital, London; City Hospital, Belfast; Royal Victoria Hospital, Belfast; St Helier Hospital, Carshalton; Whittington Hospital, London; Norfolk and Norwich Hospital; Lister Hospital, Stevenage; Ninewells Hospital, Dundee; Northampton Hospital; Torbay Hospital; Peterborough General Hospital; Scarborough Hospital; Derbyshire Royal Infirmary; Manchester Royal Infirmary; Hope Hospital, Salford; Leicester General Hospital; Royal Devon and Exeter Hospital.
Coordinating centre
Chief investigators: R C Turner, R R Holman; additional investigators: D R Matthews, H A W Neil; Statisticians: I M Stratton, C A Cull, H J McElroy, Z Mehta; biochemist: S E Manley; research associate: V Frighi: consultant statistician: R Peto; epidemiologist: A I Adler; administrator: P A Bassett; end point assessors: D R Matthews (Oxford), A D Wright (Birmingham), T L Dornan (Salford); retinal photography grading: E M Kohner, S Aldington, H Lipinski, R Collum, K Harrison, C MacIntyre, S Skinner, A Mortemore, D Nelson, S Cockley, S Levien, L Bodsworth, R Willox, T Biggs, S Dove, E Beattie, M Gradwell, S Staples, R Lam, F Taylor, L Leung (Hammersmith); dietician: E A Eeley (Oxford); biochemistry laboratory staff: M J Payne, R D Carter, S M Brownlee, K E Fisher, K Islam, R Jelfs, P A Williams, F A Williams, P J Sutton, A Ayres, L J Logie, C Lovatt, M A Evans, L A Stowell; consultant biochemist: I Ross (Aberdeen); Applications Programmer: I A Kennedy; Database clerk: D Croft; ECG Coding: A H Keen, C Rose (Guy's Hospital); Health Economists: M Raikou, A M Gray, A J McGuire, P Fenn (Oxford); Quality of Life Questionnaire: Z Mehta (Oxford), A E Fletcher, C Bulpitt, C Battersby (Hammersmith), J S Yudkin (Whittington); Mathematical Modeller: R Stevens (Oxford).
Clinical centres
M R Stearn, S L Palmer, M S Hammersley, S L Franklin, R S Spivey, J C Levy, C R Tidy, N J Bell, J Steemson, B A Barrow, R Coster, K Waring, L Nolan, E Truscott, N Walravens, L Cook, H Lampard, C Merle, P Parker, J McVittie, I Draisey (Oxford); L E Murchison, A H E Brunt, M J Williams, D W Pearson, X M P Petrie, M E J Lean D Walmsley, F Lyall, E Christie, J Church, E Thomson, A Farrow, J M Stowers, M Stowers, K McHardy, N Patterson (Aberdeen); A D Wright, N A Levi, A C I Shearer, R J W Thompson, G Taylor, S Rayton, M Bradbury, A Glover, A Smyth-Osbourne, C Parkes, J Graham, P England, S Gyde, C Eagle, B Chakrabarti, J Smith, J Sherwell (Birmingham); N W Oakley, M A Whitehead, G P Hollier, T Pilkington, J Simpson, M Anderson, S Martin, J Kean, B Rice, A Rolland, J Nisbet (London, St Georges's); E M Kohner, A Dornhorst, M C Doddridge, M Dumskyj, S Walji, P Sharp, M Sleightholm, G Vanterpool, C Rose, G Frost, M Roseblade, S Elliott, S Forrester, M Foster, K Myers, R Chapman (London, Hammersmith); J R Hayes, R W Henry, M S Featherston, G P R Archbold, M Copeland, R Harper, I Richardson, S Martin, M Foster, H A Davison (City Hospital, Belfast); L Alexander, J H B Scarpello, D E Shiers, R J Tucker, J R H Worthington, S Angris, A Bates, J Walton, M Teasdale, J Browne, S Stanley, B A Davis, R C Strange (Stoke-on-Trent); D R Hadden, L Kennedy, A B Atkinson, P M Bell, D R McCance, J Rutherford, A M Culbert, C Hegan, H Tennet, N Webb, I Robinson, J Holmes, M Foster, J Rutherford, S Nesbitt (Royal Victoria Hospital, Belfast); A S Spathis, S Hyer, M E Nanson, L M James, J M Tyrell, C Davis, P Strugnell, M Booth, H Petrie, D Clark, B Rice, S Hulland, J L Barron (Carshalton); J S Yudkin, B C Gould, J Singer, A Badenoch, S Walji, M McGregor, L Isenberg, M Eckert, K Alibhai, E Marriot, C Cox, R Price, M Fernandez, A Ryle, S Clarke, G Wallace, E Mehmed, J A Lankester, E Howard, A Waite, S MacFarlane (London, Whittington); R H Greenwood, J Wilson, M J Denholm, R C Temple, K Whitfield, F Johnson, C Munroe, S Gorick, E Duckworth, M Flatman, S Rainbow (Norwich); L J Borthwick, D J Wheatcroft, R J Seaman, R A Christie, W Wheatcroft, P Musk, J White, S McDougal, M Bond, P Raniga (Stevenage); J L Day, M J Doshi, J G Wilson, J R Howard-Williams, H Humphreys, A Graham, K Hicks, S Hexman, P Bayliss, D Pledger (Ipswich); R W Newton, R T Jung, C Roxburgh, B Kilgallon, L Dick, M Foster, N Waugh, S Kilby, A Ellingford, J Burns (Dundee); C V Fox, M C Holloway, H M Coghill, N Hein, A Fox, W Cowan, M Richard, K Quested, S J Evans (Northampton); R B Paisey, N P R Brown, A J Tucker, R Paisey, F Garrett, J Hogg, P Park, K Williams, P Harvey, R Wilcocks, S Mason, J Frost, C Warren, P Rocket, L Bower (Torbay); J M Roland, D J Brown, J Youens, K Stanton-King, H Mungall, V Ball, W Maddison, D Donnelly, S King, P Griffin, S Smith, S Church, G Dunn, A Wilson, K Palmer (Peterborough); P M Brown, D Humphriss, A J M Davidson, R Rose, L Armistead, S Townsend, P Poon (Scarborough); I D A Peacock, N J C Culverwell, M H Charlton, B P S Connolly, J Peacock, J Barrett, J Wain, W Beeston, G King, P G Hill (Derby); A J M Boulton, A M Robertson, V Katoulis, A Olukoga, H McDonald, S Kumar, F Abouaesha, B Abuaisha, E A Knowles, S Higgins, J Booker, J Sunter, K Breislin, R Parker, P Raval, J Curwell, H Davenport, G Shawcross, A Prest, J Grey, H Cole, C Sereviratne (Manchester); R J Young, T L Dornan, J R Clyne, M Gibson, I O'Connell, L M Wong, S J Wilson, K L Wright, C Wallace, D McDowell (Salford); A C Burden, E M Sellen, R Gregory, M Roshan, N Vaghela, M Burden, C Sherriff, S Mansingh, J Clarke, J Grenfell (Leicester); J E Tooke, K MacLeod, C Seamark, M Rammell, C Pym, J Stockman, C Yeo, J Piper, L Leighton, E Green, M Hoyle, K Jones, A Hudson, A J James, A Shore, A Higham, B Martin (Exeter)
Committees
UKPDS data committee: C A Cull, V Frighi, R R Holman, S E Manley, D R Matthews, H A W Neil, I M Stratton, R C Turner.
Data monitoring and ethics committee: W J H Butterfield, W R S Doll, R Eastman, F R Ferris, R R Holman, N Kurinij, R Peto, K McPherson, R F Mahler, T W Meade, G Shafer, R C Turner, P J Watkins.
Policy advisory group: C V Fox, D R Hadden, R R Holman, D R Matthews, R C Turner, A D Wright, J S Yudkin.
Steering committee for glucose study: D J Betteridge, R D Cohen, D Currie, J Darbyshire, J V Forrester, T Guppy, R R Holman, D G Johnston, A McGuire, M Murphy, A M el-Nahas, B Pentecost, D Spiegelhalter, R C Turner.
Additional funding: Medical Research Council, British Diabetic Association, the UK Department of Health, the US National Eye Institute and the US National Institute of Diabetes, Digestive and Kidney Disease in the National Institutes of Health, United States, the British Heart Foundation, The Wellcome Trust, Charles Wolfson Charitable Trust, the Clothworkers' Foundation, the Health Promotion Research Trust, the Alan and Babette Sainsbury Trust, The Oxford University Medical Research Fund Committee. Novo-Nordisk, Bayer, Bristol-Myers Squibb, Hoechst, Lilly, Lipha and Farmitalia Carlo Erba. British Diabetic Association members. GlaxoWellcome, SmithKline Beecham, Pfizer, Zeneca, Pharmacia and Upjohn, Boehringer Mannheim, Becton Dickinson, Owen Mumford, Securicor, Kodak and Cortecs Diagnostics.
Related articles
- This Week In The BMJ Published: 12 August 2000; BMJ 321 doi:10.1136/bmj.321.7258.0/b
- Editorial Published: 12 August 2000; BMJ 321 doi:10.1136/bmj.321.7258.394
- Research Published: 22 May 2008; BMJ 336 doi:10.1136/bmj.39534.571644.BE
- Research Published: 17 May 2010; BMJ 340 doi:10.1136/bmj.c2249
- Research Published: 06 September 2007; BMJ 335 doi:10.1136/bmj.39314.620174.80
- RESEARCH Published: 30 August 2007; BMJ doi:10.1136/bmj.39314.620174.80
- Research Published: 08 January 2010; BMJ 340 doi:10.1136/bmj.b4909
- Clinical Review Published: 07 December 2006; BMJ 333 doi:10.1136/bmj.39022.462546.80
- Research Published: 26 July 2011; BMJ 343 doi:10.1136/bmj.d4169
- Research Published: 30 July 2013; BMJ 347 doi:10.1136/bmj.f4533
- Letter Published: 19 May 2001; BMJ 322 doi:10.1136/bmj.322.7296.1245/b
- Research Published: 30 March 2016; BMJ 352 doi:10.1136/bmj.i1450
- Research Published: 13 July 2016; BMJ 354 doi:10.1136/bmj.i3477
- Practice Published: 06 September 2007; BMJ 335 doi:10.1136/bmj.39255.669444.AE
- Letter Published: 27 March 2008; BMJ 336 doi:10.1136/bmj.39520.531319.3A
- Research Published: 17 May 2018; BMJ 361 doi:10.1136/bmj.k1959
- Clinical Review Published: 05 November 2019; BMJ 367 doi:10.1136/bmj.l5887
- Research Published: 03 October 2022; BMJ 379 doi:10.1136/bmj-2022-070717
See more
- Diabetes: Doctors are told not to start new patients on GLP-1 agonists because of shortagesBMJ September 01, 2023, 382 p2019; DOI: https://doi.org/10.1136/bmj.p2019
- UK clinics told to stop prescribing antidiabetes drugs for weight loss, after shortagesBMJ July 21, 2023, 382 p1693; DOI: https://doi.org/10.1136/bmj.p1693
- Tackling structural racism is crucial to ending global diabetes crisis, researchers sayBMJ June 22, 2023, 381 p1439; DOI: https://doi.org/10.1136/bmj.p1439
- Diabetes: Missed routine checks are causing premature deaths in England, charity warnsBMJ May 10, 2023, 381 p1070; DOI: https://doi.org/10.1136/bmj.p1070
- Rise in type 2 diabetes shows that prevention is more important than everBMJ April 25, 2023, 381 p910; DOI: https://doi.org/10.1136/bmj.p910
Cited by...
- 100 most-cited articles on diabetic retinopathy
- EXTending availability of self-management structured EducatioN programmes for people with type 2 Diabetes in low-to-middle income countries (EXTEND)--a feasibility study in Mozambique and Malawi
- Time In Range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes- A systemic review
- Antihyperglycemic Algorithms for Type 2 Diabetes: Focus on Nonglycemic Outcomes
- Sodium-Glucose Cotransporter 2 Inhibitors and the Kidney
- Inconvenient relationship of haemoglobin A1c level with endothelial function in type 2 diabetes in a cross-sectional study
- Efficacy and Safety of Mulberry Twig Alkaloids Tablet for the Treatment of Type 2 Diabetes: A Multicenter, Randomized, Double-Blind, Double-Dummy, and Parallel Controlled Clinical Trial
- Effects of recreational sports and combined training on blood pressure and glycosylated hemoglobin in middle-aged and older adults: a systematic review and meta-analysis
- Does the Association Between Hemoglobin A1c and Risk of Cardiovascular Events Vary by Residential Segregation? The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study
- Identifying sustainable lifestyle strategies for maintaining good glycemic control: a validation of qualitative findings
- Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
- Rationale for the Use of Combination Injectable Therapy in Patients With Type 2 Diabetes Who Have High A1C (>=9%) and/or Long Duration (>8 Years): Executive Summary
- Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: the population-based Tromso Study 1994-2016
- Machine-Learning Powered Optoacoustic Sensor for Diabetes Progression
- Casual blood glucose and subsequent cardiovascular disease and all-cause mortality among 159 731 participants in Cohort of Norway (CONOR)
- Lifestyle Intervention in Chronic Ischaemic Heart Disease and Type 2 Diabetes (the LeIKD study): study protocol of a prospective, multicentre, randomised, controlled trial
- Glycemic Control and Risk of Cellulitis
- Association of Diet Quality Indices with Longitudinal Changes in Kidney Function in U.S. Hispanics/Latinos: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
- Service user and community clinician design of a partially virtual diabetic service improves access to care and education and reduces amputation incidence
- 6. Glycemic Targets: Standards of Medical Care in Diabetes--2021
- Impact of providing patients access to electronic health records on quality and safety of care: a systematic review and meta-analysis
- Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice
- Trends in known and undiagnosed diabetes, HbA1c levels, cardio-metabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys - The Tromso Study 1994-2016
- Reversal of diabetic tractional retinal detachment attributed to keto diet
- Predictors for diabetic retinopathy progression--findings from nominal group technique and Evidence review
- Effective Initiation and Treatment With Basal Insulin in People With Type 2 Diabetes: Focus on Mitigating Hypoglycemia in Patients at Increased Risk: Executive Summary
- Epigenetic markers associated with metformin response and intolerance in drug-naïve patients with type 2 diabetes
- Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management
- The Affordable Care Act: Effects of Insurance on Diabetes Biomarkers
- Impact of Physician-Pharmacist Collaboration on Diabetes Outcomes and Health Care Use
- Monitoring, treatment and control of blood glucose and lipids in Ontario First Nations people with diabetes
- Newly Discovered Abnormal Glucose Tolerance in Patients With Acute Myocardial Infarction and Cardiovascular Outcomes: A Meta-analysis
- Diabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association
- Development and validation of prediction rules to target care intensification in veteran patients with diabetes
- The effect of 'paying for performance on the management of type 2 diabetes mellitus: a cross-sectional observational study
- Evaluating the effectiveness of a support programme for people with type 2 diabetes mellitus in primary care: an observational prospective study in Ecuador
- Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial
- Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM
- HbA1c as a predictor for response of bevacizumab in diabetic macular oedema
- Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials
- Association between GP participation in a primary care group and monitoring of biomedical and lifestyle target indicators in people with type 2 diabetes: a cohort study (ELZHA cohort-1)
- Diabetes-induced eye disease among First Nations people in Ontario: a longitudinal, population-based cohort study
- Comprehensive Glycomic Analysis Reveals That Human Serum Albumin Glycation Specifically Affects the Pharmacokinetics and Efficacy of Different Anticoagulant Drugs in Diabetes
- Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain
- Observational stepped-wedge analysis of a community health worker-led intervention for diabetes and hypertension in rural Mexico
- Levels of ankle-brachial index and the risk of diabetes mellitus complications
- 'We do not seem to engage with dentists: a qualitative study of primary healthcare staff and patients in the North East of England on the role of pharmacists in oral healthcare
- Supporting care for suboptimally controlled type 2 diabetes mellitus in general practice with a clinical decision support system: a mixed methods pilot cluster randomised trial
- Therapeutic Inertia in People With Type 2 Diabetes in Primary Care: A Challenge That Just Wont Go Away
- Limitations of hemoglobin A1c in the management of type 2 diabetes mellitus
- Uptake of best practice recommendations in the management of patients with diabetes and periodontitis: a cross-sectional survey of healthcare professionals in primary care
- Low-energy total diet replacement intervention in patients with type 2 diabetes mellitus and obesity treated with insulin: a randomized trial
- Obesity-linked PPAR{gamma} S273 phosphorylation promotes insulin resistance through Growth Differentiation Factor 3
- 6. Glycemic Targets: Standards of Medical Care in Diabetes--2020
- Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort Study
- Six-year incidence and progression of diabetic retinopathy in Indian adults: the Singapore Indian Eye study
- Redesigning ambulatory care management for uncontrolled type 2 diabetes: a prospective cohort study of the impact of a Boot Camp model on outcomes
- Benefits and harms of intensive glycemic control in patients with type 2 diabetes
- Increased Expression of Ecto-NOX Disulfide-thiol Exchanger 1 (ENOX1) in Diabetic Mice Retina and its Involvement in Diabetic Retinopathy Development
- Clinically meaningful visual improvements and predictors of early vision gains with ranibizumab for diabetic macular oedema
- Disturbed Fatty Acid Oxidation, Endoplasmic Reticulum Stress, and Apoptosis in Left Ventricle of Patients With Type 2 Diabetes
- Quality of medical products for diabetes management: a systematic review
- Sodium nitroprusside prevents the detrimental effects of glucose on the neurovascular unit and behaviour in zebrafish
- Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)
- Controversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common Ground
- Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study
- Text messaging support for patients with diabetes or coronary artery disease (SupportMe): protocol for a pragmatic randomised controlled trial
- Comparative Effectiveness and Maintenance of Diabetes Self-Management Education Interventions for Marshallese Patients With Type 2 Diabetes: A Randomized Controlled Trial
- Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice
- Initiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions
- Sodium nitroprusside prevents the detrimental effects of glucose on the neurovascular unit and behaviour in zebrafish
- Eligibility of patients with type 2 diabetes for sodium-glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study
- Association between full monitoring of biomedical and lifestyle target indicators and HbA1c level in primary type 2 diabetes care: an observational cohort study (ELZHA-cohort 1)
- Incidence and Determinants of Intraocular Lens Implantation in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
- Trained immunity and diabetic vascular disease
- Dietary Approaches to the Management Of type 2 Diabetes (DIAMOND): protocol for a randomised feasibility trial
- 6. Glycemic Targets: Standards of Medical Care in Diabetes--2019
- Accumulated or continuous exercise for glycaemic regulation and control: a systematic review with meta-analysis
- Supported self-management for people with type 2 diabetes: a meta-review of quantitative systematic reviews
- Reprint of: Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention: JACC Health Promotion Series
- Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention: JACC Health Promotion Series
- Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes: A Network Meta-Analysis
- Amelioration of Diabetic Nephropathy Using a Retinoic Acid Receptor {beta}2 Agonist
- Preventing Heart Failure in Diabetes: Glycemic Targets or Class Effect?
- Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data
- Inhibition of the CD36 receptor reduces visceral fat accumulation and improves insulin resistance in obese mice carrying the BDNF-Val66Met variant
- Cardiovascular benefits of GLP-1 agonists in type 2 diabetes: a comparative review
- GOAL study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice
- Impact of a multidisciplinary intensive education program on type 2 diabetes mellitus patients glycemic control and cardiovascular risk factors
- SMS-based intervention in type 2 diabetes: clinical trial in Senegal